ABCC1 and hepatocellular carcinoma: It was reported that ABCC1 was significantly upregulated in the tissues of oxaliplatin-resistant, 5-fluorouracil-resistant, and sorafenib-resistant HCC patients (Ding et al., 2017; Huang et al., 2018; Ding et al., 2019).